Metabolic and cardiovascular benefits of GLP-1 agonists, besides the hypoglycemic effect (Review)

Patients with type 2 diabetes exhibit higher cardiovascular risk than normal individuals. Optimal blood glucose levels are rarely achieved in diabetic patients. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as a new antidiabetic drug class with multiple metabolic effects. Some t...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Exp Ther Med
Huvudupphovsmän: Iorga, Roua Anamaria, Bacalbasa, Nicolae, Carsote, Mara, Bratu, Ovidiu Gabriel, Stanescu, Ana Maria Alexandra, Bungau, Simona, Pantis, Carmen, Diaconu, Camelia Cristina
Materialtyp: Artigo
Språk:Inglês
Publicerad: D.A. Spandidos 2020
Ämnen:
Review
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7401476/
https://ncbi.nlm.nih.gov/pubmed/32765722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2020.8714
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk